- Last known well (LKW) is the clock. Call the stroke code, check glucose, get non-contrast CT + CTA.
- Disabling deficit ≤4.5 h, no contraindication → IV tenecteplase 0.25 mg/kg (max 25 mg) or alteplase 0.9 mg/kg. 2026: both first-line.
- Large-vessel occlusion → thrombectomy up to 24 h — plan lysis and EVT in parallel.
- BP: <185/110 before lysis, <180/105 for 24 h after. No lysis → permissive up to 220/120.
- Minor stroke (NIHSS ≤3) or high-risk TIA → DAPT (aspirin + clopidogrel) × 21 days, then single agent.
Pathophysiology in 60 seconds
⌄
- Artery blocked → core (dead) + penumbra (stunned, salvageable). Penumbra dies by the minute: ~1.9 million neurons/min.
- Causes (TOAST): large-artery atherosclerosis, cardioembolic (AF!), small vessel (lacunar), other (dissection, vasculitis, hypercoagulable), cryptogenic/ESUS.
- TIA = transient symptoms without infarct on MRI. High early stroke risk (most in 48 h).
- 0–4.5 h
IV tenecteplase 0.25 mg/kg (max 25 mg) or alteplase 0.9 mg/kg — if disabling deficit and no contraindication
- 0–24 h
LVO on CTA → thrombectomy (EVT); lysis and EVT planned in parallel
- 4.5–24 h
Selected patients with salvageable tissue on advanced imaging may still get lysis
- After
BP <180/105 for 24 h after lysis; swallow screen; antiplatelet at 24 h (if no lysis bleed)
Diagnosis
⌄
- NIHSS (0–42). Disabling = would stop the patient from basic activities or work (aphasia, hemianopia, weakness), even if NIHSS low.
- Imaging: non-contrast CT (bleed?) → CTA head/neck (LVO?) → CT perfusion/MRI for late windows.
- Mimics: hypoglycemia, seizure (Todd's), migraine, sepsis/toxic, conversion, old stroke "unmasked."
- ABCD² for TIA: Age ≥60 (1), BP ≥140/90 (1), Clinical: weakness (2) / speech only (1), Duration ≥60 min (2) / 10–59 (1), Diabetes (1). ≥4 = high risk.
| Major lysis contraindications (check full list) |
|---|
| Intracranial hemorrhage on CT · ischemic stroke/head trauma <3 months · intracranial surgery <3 months · GI bleed <21 days · platelets <100 k · INR >1.7 · therapeutic LMWH <24 h · DOAC within 48 h (unless normal specific level/reversal) · BP not controlled · glucose <50 (treat and reassess) |
Management
⌄
- Tenecteplase 0.25 mg/kg single bolus (max 25 mg) — not 0.4 mg/kg (harm).
- Or alteplase 0.9 mg/kg (max 90 mg): 10% bolus, rest over 60 min.
- BP before lysis: labetalol 10–20 mg IV, nicardipine 5 mg/h titrate, clevidipine.
- No antithrombotics for 24 h after lysis; repeat CT at 24 h.
- Angioedema (ACEi users) → stop infusion, methylprednisolone, diphenhydramine, famotidine; airway.
- Symptomatic ICH after lysis → stop, cryoprecipitate 10 U, TXA, neurosurgery.
- Swallow screen before anything by mouth.
- Glucose 140–180. Treat fever. Head of bed by aspiration risk.
- DVT prophylaxis: intermittent pneumatic compression (CLOTS-3) ± LMWH (after 24 h if lysed).
- Workup: MRI, vessel imaging, TTE (± bubble), telemetry → long-term monitor if cryptogenic, A1c, lipids.
- PT/OT/speech; rehab planning.
| Situation | Therapy |
|---|---|
| Minor stroke / high-risk TIA | Aspirin + clopidogrel 21 days (load clopidogrel 300–600 mg) |
| Other non-cardioembolic | Aspirin or clopidogrel |
| AF | DOAC; start early: within 48 h for minor/moderate, ~day 6–7 for major (ELAN, OPTIMAS) |
| Symptomatic carotid stenosis 70–99% | CEA within 2 weeks (stenting selected) |
| All | High-intensity statin, LDL <70 (TST) · BP <130/80 · smoking cessation · diabetes control |
| PFO + young cryptogenic | PFO closure (selected) |
- SBP target ~140 (keep 130–150; avoid big drops).
- Reverse anticoagulation: warfarin → 4F-PCC + vit K · factor Xa → andexanet or 4F-PCC · dabigatran → idarucizumab.
- No platelet transfusion for antiplatelet ICH (PATCH) unless surgery.
- Neurosurgery for cerebellar ICH >3 cm, hydrocephalus.
Pitfalls
⌄
- Waiting for labs (except glucose) or MRI before tPA/TNK.
- Treating BP to "normal" in the first days without lysis → infarct growth.
- Letting a patient eat before swallow screen → aspiration pneumonia.
- Heparin drips for acute stroke (no benefit, more bleeding).
Board corner
⌄
| Stem | Answer |
|---|---|
| Aphasia, LKW 2 h ago, BP 200/110 | Lower BP <185/110 → thrombolysis |
| NIHSS 2, non-disabling, LKW 1 h | Antiplatelet (DAPT), not lysis |
| M1 occlusion, LKW 14 h, good perfusion mismatch | Thrombectomy |
| TIA, 80% ipsilateral carotid stenosis | CEA within 2 weeks |
| Stroke + new AF, small infarct | Start DOAC within ~48 h |
References
⌄
- Prabhakaran S, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2026. doi:10.1161/STR.0000000000000513
- Kleindorfer DO, et al. 2021 Guideline for Prevention of Stroke in TIA/Stroke. Stroke. 2021;52:e364.
- Greenberg SM, et al. 2022 Guideline for Spontaneous ICH. Stroke. 2022;53:e282.
- POINT · CHANCE · ELAN · OPTIMAS · CLOTS-3.